AURA NASDAQ
Aura Biosciences, Inc.
1W: +5.0%
1M: +4.4%
3M: -1.5%
YTD: +35.1%
1Y: +1.4%
3Y: -40.0%
$7.05
-0.11 (-1.54%)
Weekly Expected Move ±10.3%
$6
$6
$7
$8
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$452.6M
52W Range4.73-9.535
Volume435,840
Avg Volume667,680
Beta0.40
Dividend—
Analyst Ratings
Company Info
CEONatalie C. Holles
Employees113
SectorHealthcare
IndustryBiotechnology
IPO Date2021-10-29
Websiteaurabiosciences.com
85 Bolton Street
Boston, MA 02140
US
Boston, MA 02140
US
617 500 8864
About Aura Biosciences, Inc.
Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases.
Latest News
Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights
Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday
Aura Biosciences prices $260M stock, warrant offering
Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bender Jeremy | A-Award | 30,000 | — | 2026-07-07 |
| Bender Jeremy | A-Award | 60,000 | $7.03 | 2026-07-07 |
| Bender Jeremy | 0 | — | 2026-07-07 | |
| Kilroy Conor | A-Award | 14,858 | — | 2026-07-01 |
| Gibney Anthony S | S-Sale | 12,824 | $6.42 | 2026-06-16 |